Verbeek, Rutger
Hovingh, G. Kees
Article History
First Online: 9 November 2017
Competing interests
: R.V. declares no competing interests. G.K.H. has participated in advisory boards for and has received lecture fees (for lectures on lipid-lowering therapy in general) from Amgen, Sanofi-Aventis and Regeneron, and has received lecture fees (for lectures about lipid-lowering therapy in general) from Pfizer.